Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by jwalliscaon Nov 22, 2019 11:03am

97 Views

Post# 30382387

edrose now on IGNORE, unbelievable that person :(

BT, MS2, Rb2211, e1, S7... et al

This is the first time I have used IGNORE on Stockhouse and edrose gets the PLATINUM medal for that achievment.... truly an annoyingly, unbelieveable "person"??? (Maybe note even a person???)

As for Sernova, I am even more convinced now that no news is coming until we get either a procedural release (e.g. Swetlow new CFO), or a BlockBuster Release (e.g. Buy, Bye).

Timing wise and cashflow wise, it goes to cause that we now have three with the pouch... the original numero uno and now, with the PP money, the two other original enrolled cohorts. I have already guessed the timeframe as late November to mid-December, but Sernova has a more accurate schedule than my estimates.